Difficulty: Medium
Average Score: 80%
Practice
Mucoviscidosis would also predispose Sonya to later development of which of the following lung disorder?
Correct answer
C
Rationale
In this pediatric respiratory assessment scenario, the correct answer is C) Pneumothorax. Mucoviscidosis, also known as cystic fibrosis, is a genetic disorder that affects the mucus and sweat glands in the body. In the lungs, the abnormally thick and sticky mucus can lead to recurrent lung infections and blockages in the airways. Over time, this can cause lung damage and complications such as pneumothorax, which is the presence of air or gas in the pleural cavity, leading to lung collapse.
Option A) Pleural effusion is an abnormal accumulation of fluid in the pleural space, which is not directly linked to mucoviscidosis.
Option B) Obstructive emphysema is a chronic obstructive pulmonary disease (COPD) characterized by damage to the air sacs in the lungs, typically caused by smoking or environmental factors, rather than mucoviscidosis.
Option D) Tuberculosis is a bacterial infection that primarily affects the lungs and is not specifically associated with mucoviscidosis.
Educationally, it is important to understand the respiratory complications associated with genetic disorders like mucoviscidosis to provide comprehensive care to pediatric patients. By recognizing the potential development of pneumothorax in these patients, healthcare providers can monitor and intervene early to prevent serious respiratory complications.
Option A) Pleural effusion is an abnormal accumulation of fluid in the pleural space, which is not directly linked to mucoviscidosis.
Option B) Obstructive emphysema is a chronic obstructive pulmonary disease (COPD) characterized by damage to the air sacs in the lungs, typically caused by smoking or environmental factors, rather than mucoviscidosis.
Option D) Tuberculosis is a bacterial infection that primarily affects the lungs and is not specifically associated with mucoviscidosis.
Educationally, it is important to understand the respiratory complications associated with genetic disorders like mucoviscidosis to provide comprehensive care to pediatric patients. By recognizing the potential development of pneumothorax in these patients, healthcare providers can monitor and intervene early to prevent serious respiratory complications.